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Abstract: We have previously shown that the C-type Natriuretic Peptide (CNP), a peptide produced
by lungs, is able to impact Pseudomonas aeruginosa physiology. In the present work, the effect of
CNP at different concentrations on P. aeruginosa biofilm formation was studied and the mechanisms
of action of this human hormone on P. aeruginosa were deciphered. CNP was shown to inhibit
dynamic biofilm formation in a dose-dependent manner without affecting the bacterial growth at any
tested concentrations. The most effective concentrations were 1 and 0.1 µM. At 0.1 µM, the biofilm
formation inhibition was fully dependent on the CNP sensor protein AmiC, whereas it was only
partially AmiC-dependent at 1 µM, revealing the existence of a second AmiC-independent mode
of action of CNP on P. aeruginosa. At 1 µM, CNP reduced both P. aeruginosa adhesion on glass and
di-rhamnolipid production and also increased the bacterial membrane fluidity. The various effects
of CNP at 1 µM and 0.1 µM on P. aeruginosa shown here should have major consequences to design
drugs for biofilm treatment or prevention.
Keywords: biofilm; hormones; peptides; bacterial adaptation; lung; cystic fibrosis
1. Introduction
The biofilm lifestyle largely adopted by bacteria allows their protection against environmental
stresses including those induced by biocides or antibiotics [1], leading to persistency and chronic
infections [2]. Indeed, biofilm-associated bacteria appear less sensitive to antibiotics than their
planktonic counterparts [3]. Antibiotics have played a key role in our civilization through their
ability to cure the great majority of bacterial infections, but, because of the huge diversity of bacteria,
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their high-speed reproduction, and adaptability, they also progressively promoted a selection of the
most resistant strains. This constitutes a new challenge for treating bacterial infections [4]. In this
context, the principle of a bi-therapeutic approach, in which an anti-biofilm compound is used to
restore the bacterial sensitivity to co-administrated antibiotics [5,6], constitutes a promising strategy
to develop new anti-bacterial treatments [7]. However, if the principle is elegant, its application is
not obvious as it has been observed that bacteria can also develop resistances against anti-biofilm
compounds, such as cationic antimicrobial peptides (CAMP) through activation of various sensors
and transduction systems [8–10].
A new approach for discovering natural and potentially low toxicity antibacterial molecules
consisted in studying host-bacterium communication and particularly the impact of eukaryotic signal
molecules (i.e., cytokines, hormones, and neurotransmitters) on both bacterial virulence traits and
biofilm formation. This idea emerged under the initiative of Mark Lyte who first demonstrated that
bacteria, such as Escherichia coli, are sensitive to epinephrine [11]. This opened a completely new
field of research known as microbial endocrinology [12]. Since then, numerous eukaryotic signal
compounds able to modify bacterial physiology have been identified [13–16]. In addition to their
ability to modify bacterial virulence or production of quorum sensing molecules, the impact on biofilm
formation of a few of these host-produced molecules has been reported for both Gram-negative
and Gram-positive bacteria. For instance, it has been shown that the neuropeptide substance P (SP)
produced by skin nerves is able to enhance both Staphylococcus aureus and S. epidermidis binding to
keratinocytes and favors S. epidermidis biofilm formation [17]. The SP spectrum of activity is large
since biofilm formation by Bacillus cereus was also enhanced by SP [18]. The regulation of biofilm
formation by neuropeptides appears complex since, in contrast to SP, the Calcitonin Gene-Related
Peptide (CGRP) impairs S. epidermidis biofilm formation [19]. It is interesting to note that these bacterial
effects of human peptides described above, are consecutive to the binding of the molecules by specific
bacterial receptors/sensors acting with a similar sensitivity as their human counterparts. In addition to
the effects of neuropeptides on biofilm formation, it has been reported that the small stress hormones,
epinephrine, and norepinephrine, enhanced biofilm formation in E. coli [20,21].
Now the same question arises for Pseudomonas aeruginosa, for which resistance to antibiotic
treatments is largely attributed to its transition from a planktonic to a biofilm lifestyle in the host [22–24].
The high adaptability of P. aeruginosa to the host environment strongly suggests that it can detect a
large range of eukaryotic chemical signals [25,26]. Indeed, the neurotransmitter γ-aminobutyric acid
(GABA) known to be able to bind a Pseudomonas protein [27], slightly inhibits both P. aeruginosa [28] and
P. fluorescens biofilm formation [29]. Another study showed that the endogenous opioid dynorphin A
modifies the production of P. aeruginosa quorum sensing autoinducers triggering bacterial physiology
modifications [30]. In addition, opioid receptor agonists are able to mimic the effect of dynorphin
A on P. aeruginosa, especially by enhancing bacterial adhesion properties [30], suggesting that this
effect is relayed by a bacterial sensor. A first hypothesis suggested that dynorphin A was able to bind
the global transcriptional regulator MvfR, after passive diffusion through bacterial membranes [30].
However, a recent study using new chemical probes identified the membrane sensor kinase ParS
of the ParR/ParS two component system as the bacterial sensor for dynorphin A [31]. In the same
vein, the cytokine Interferon-γ was shown to induce modifications in P. aeruginosa virulence traits via
binding to the major outer membrane protein OprF [32]. OprF is a porin that fulfills multiple functions
in P. aeruginosa [33] including regulation of virulence [34] and biofilm formation [35].
Altogether, these data show that activation of some bacterial sensors by human communication
compounds favors bacterial adhesion and biofilm formation making thus these compounds not
appropriate for developing therapeutic approaches. However, a much better candidate could be
the C-type Natriuretic Peptide (CNP). CNP is a member of the natriuretic peptide family also
including the Atrial Natriuretic Peptide (ANP) and the Brain Natriuretic Peptide (BNP). These three
hormones are released by mammalian cardiomyocytes and endothelial cells in order to regulate
cardiovascular homeostasis and blood pressure [36]. It has been shown that the release of natriuretic
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peptides (BNP and CNP) in blood is enhanced in presence of Gram-negative bacteria or the endotoxin
lipopolysaccharide (LPS) [37]. In the same vein, in vitro study has demonstrated that endothelial
cells exposed to LPS secreted more CNP (×25) than control cells [38]. These data suggest that during
the infectious process Gram-negative bacteria, including P. aeruginosa, are exposed to natriuretic
peptides secreted locally. In parallel, it has been shown that hBNP (but not hCNP) possesses an
antimicrobial activity against numerous micro-organisms [39]. Altogether, these data prompted us to
investigate deeper the potential activity of BNP and CNP on P. aeruginosa. We first observed that CNP
used at 1 µM slightly enhanced P. aeruginosa virulence [40]. Since virulence and biofilm formation
are inversely regulated in P. aeruginosa, we naturally investigated the effect of natriuretic peptides,
and more particularly CNP, on P. aeruginosa biofilm formation. As expected, we observed that CNP at
0.1 µM strongly reduced the biofilm formation and that this action is mediated through specific CNP
recognition by a bacterial sensor identified as the AmiC protein [41].
In the present study, we decided to investigate the dose-related effects of CNP on P. aeruginosa
biofilm formation. Using several concentrations, we observed that CNP inhibited biofilm formation in
a dose-dependent manner. The most efficient concentrations are 1 and 0.1 µM. The impact of CNP on
P. aeruginosa at 1 µM appeared only partly relayed through binding to AmiC, suggesting that CNP has
multiple modes of action on P. aeruginosa.
2. Results
2.1. Effect of CNP on P. aeruginosa Biofilm Formation in Dynamic Conditions
We previously observed that CNP at a concentration of 0.1 µM strongly inhibited (−78%; p < 0.001)
the formation of P. aeruginosa PA14 biofilms grown for 24 h on glass slide under a constant medium
flow [41]. Administration of CNP at 1 µM in the same condition induced a strong (−81.0 ± 6.3%) and
significant (p < 0.001) decrease of the biofilm production when compared to biofilms grown without
CNP (Figure 1A). In addition, we observed that CNP used at 10 nM for 24 h reduced by 46.9 ± 6.7%
(p < 0.001) the P. aeruginosa ability to form a biofilm (Figure 1A). In parallel, we observed that at this
concentration the CNP reduced the built-up of mushroom-like structures (Figure 1B). Finally, CNP used
at 1 nM failed to affect P. aeruginosa biofilm formation (Figure 1A,B). Taken together, these results show
that CNP impedes biofilm development of P. aeruginosa in a dose-dependent manner when tested in
dynamic conditions. In order to evaluate any CNP impact on P. aeruginosa growth, we studied the
impact of several CNP concentrations on the growth kinetisc of P. aeruginosa PA14 in liquid medium.
None of the tested CNP concentrations (i.e., 1 µM, 0.1 µM, 10 nM and 1 nM) affected bacterial growth
(Figure 2). Therefore, the defect in biofilm development observed on Figure 1A in the presence of
10 nM to 1 µM CNP cannot be explained by lower growth rates.
Figure 1. Cont.
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Figure 1. Biofilm formation in dynamic conditions by P. aeruginosa PA14 exposed to C-type Natriuretic
Peptide (CNP). (A) COMSTAT analyses of biofilms of P. aeruginosa PA14 control (blue bar) or exposed
to several concentrations of CNP (orange bars). Data are the means of four measuring fields obtained
from four independent experiments. FFF, p < 0.001; NS: not significantly different. (B) 3D-shadow
representations of the biofilm structures developed under dynamic conditions by P. aeruginosa PA14
control (left images) or exposed to CNP at 1 µM, 0.1 µM, 10 nM or 1 nM (right images). Biofilms were
stained with the Syto 61 Red dye and observed by confocal laser scanning microscopy.
Figure 2. Growth of PA14 exposed to C-type Natriuretic Peptide (CNP). Culture growth curves were
measured at OD580nm. Absorbance was recorded every 15 min for 24 h. Curves are color-coded as
follow: PA14 WT alone (blue), PA14 WT exposed to CNP (1 µM) (orange) and PA14 WT exposed to
CNP (0.1 µM). Results are the mean of eight replicates from three independent experiments. The same
kinetics have been observed when PA14 WT was exposed to CNP (10 nM and 1 nM).
2.2. Involvement of AmiC in the CNP Effect on P. aeruginosa
We previously demonstrated that the effect of 0.1 µM CNP on biofilm formation requires the
binding of CNP to the bacterial sensor AmiC [41]. We first observed that the ∆amiC mutant strain
ability to form a biofilm is strongly impaired (Figure 3B). When the ∆amiC mutant strain was exposed
to 0.1 µM CNP, the biofilm formation was not affected as compared with the corresponding control
(Figure 3A,B). In contrast, when the CNP concentration was increased to 1 µM, the ∆amiC strain
remained partially sensitive to the peptide since the biofilm was reduced by 51.4 ± 10.4% (p < 0.05)
compared to biofilm of the same mutant grown without CNP (Figure 3A,B).
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Figure 3. Biofilm formation in dynamic condition by P. aeruginosa PA14 mutant strain ∆amiC exposed to
C-type Natriuretic Peptide (CNP). (A) COMSTAT analyses of biofilms of ∆amiC mutant strain (blue bar)
exposed to CNP (1 µM; deep orange bar) or to CNP (0.1 µM; light orange bar). Data are the means of
twenty-one samples from seven independent experiments for ∆amiC control condition, six samples
from two independent experiments for ∆amiC exposed to CNP (1 µM) and twelve samples from
four independent experiments for ∆amiC exposed to CNP (0.1 µM).F, p < 0.05; NS: not significantly
different. (B) 3D-shadow representations of the biofilm structures developed under dynamic conditions
by P. aeruginosa ∆amiC control (left part) or exposed to CNP at 1 µM or 0.1 µM (right part). Biofilms were
stained with the Syto 61 Red dye and observed by confocal laser scanning microscopy.
2.3. Effect of CNP on P. aeruginosa Adhesion Properties
The formation of biofilms depends on the motility of a bacterium to colonize its environment as
well as its ability to attach to biotic and abiotic surfaces [42]. We observed that exposition to 1 µM of
CNP led to reduce the ability of the bacteria to attach to glass slides under static condition (Figure 4A).
More precisely, the surface occupied by bacteria after exposure to CNP is reduced by 24.8% (p < 0.01)
compared to control condition (i.e., P. aeruginosa not exposed to CNP peptide) (Figure 4B). In contrast,
exposition to 0.1 µM of CNP did not modify the ability of the bacteria to attach to glass slides under
static condition (Figure 4A,B).
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Figure 4. Adhesion on glass slide of P. aeruginosa PA14 exposed to C-type Natriuretic Peptide (CNP).
(A) Pictures representing the occupancy of bacteria control (left part) or bacteria exposed to CNP
(1 µM) or to CNP (0.1 µM) (right part) on glass slides. Bacteria were stained with Syto9 green dye.
(B) Percentage of recovery using ImageJ [43]. The data are the mean of six measurements realized from
two independent experiments. FF, p < 0.01. NS: not significantly different.
2.4. Effect of CNP on P. aeruginosa Di-Rhamnolipid Production
Rhamnolipids are secreted biosurfactants composed of mono- or di-rhamnose linked to a fatty
acid chain of variable length [44]. These glycolipids are surface-active and affect biofilm formation
through microcolonies formation, surface motility [45]. They also contribute to the biofilm architecture
by maintaining fluid channels between mushroom-like structures [46]. In order to evaluate the impact
of CNP on P. aeruginosa rhamnolipid production, we quantified the two most abundant di-rhamnolipid
species produced by the PAO1 strain: Rha-Rha-C10-C10 and Rha-Rha-C10-C12 [47]. We switched
to the PAO1 strain for this experiment because of our background on rhamnolipid production by
this strain [39] and because we have previously observed that PAO1 strain and PA14 strain show the
same sensitivity to CNP (1 µM) [41]. We observed that CNP (1 µM) did not modify the quantity of
Rha-Rha-C10-C10 produced after 6 h of culture (Figure 5A). In contrast, we noted that CNP induced a
deep fall (−41.1 ± 3.0%; p < 0.001) in the amount of Rha-Rha-C10-C12 produced by PAO1 after 6 h of
culture (Figure 5B).
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Figure 5. Effect of C-type Natriuretic Peptide (CNP) on rhamnolipids production by P. aeruginosa
PAO1. Relative amounts of the di-rhamnolipid Rha-Rha-C10-C10 (A) and the di-rhamnolipid
Rha-Rha-C10-C12 (B) in P. aeruginosa PAO1 supernatants, 4 h later bacteria exposure to physiologic
water (control, blue bars) or CNP 1 µM (orange bars). Data are the means of three independent
experiments. The mean of [Rha-Rha-C10-C10] and [Rha-Rha-C10-C12] levels in control conditions
were 174 × 103 Aera/OD580 and 9.7 × 103 Aera/OD580, respectively. NS: not significantly different.
FFF, p < 0.001.
2.5. Effect of CNP on P. aeruginosa Membrane Fluidity
Since attachment to surfaces and secretion of biofilm matrix molecules are both depending on
bacterial membrane fluidity [48] and since we observed a contrast concerning the mode of action
of CNP on P. aeruginosa when the peptide was utilized at 1 µM and 0.1 µM, we evaluated the CNP
impact on P. aeruginosa membrane fluidity by measuring the fluorescence polarization anisotropy (r) of
1,6-diphenyl-1,3,5-hexatriene (DPH), a lipophilic fluorescent probe. An inverse relationship occurs
between measured DPH fluorescence anisotropy and membrane fluidity [49]. Statistical analysis
of r-values shows that exposure of P. aeruginosa PA14 strain to 1 µM of CNP for 3 h triggered an
enhancement of the membrane fluidity (p < 0.001) (Figure 6). By contrast, exposure of P. aeruginosa
PA14 strain to 0.1 µM of CNP for 3 h failed to affect the membrane fluidity (Figure 6). The CNP
influence on membrane fluidity may possibly explain a part of its effect on P. aeruginosa biofilm
formation at 1 µM.
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Figure 6. Membrane fluidity of P. aeruginosa PA14 exposed to C-type Natriuretic Peptide (CNP).
The fluorescence anisotropy r-values for PA14 strain used as control (blue bar), PA14 exposed to CNP
at 1 µM (deep orange bar) and 0.1 µM (light orange bar) were obtained from 100 different wells from
five independent experiments for PA14 control condition (blue bar), in 76 different wells from four
independent experiments for PA14 exposed to CNP (1 µM; deep orange bar) and in 32 different wells
from two independent experiments for PA14 exposed to CNP (0.1 µM; light orange bar). An inverse
relationship occurred between the fluorescence anisotropy and cell membrane fluidity.FFF, p < 0.001;
NS, not significantly different.
3. Discussion
We have previously shown that CNP, which is produced by lung cells [50], is able to modify P.
aeruginosa physiology. More precisely, we observed that P. aeruginosa cytotoxicity [51] and virulence [40]
are increased after CNP exposure, while biofilm formation is strongly inhibited [41]. In the present
study, we observed that CNP has similar efficiencies when used at 0.1 and 1 µM (biofilms reduced by
about 80%), and that a concentration of 10 nM is still able to inhibit by half the capacity of P. aeruginosa
to form a biofilm in dynamic conditions. CNP thus inhibits P. aeruginosa biofilm formation in a
dose-dependent manner in the 10 nM–0.1 µM range of concentrations. Furthermore, our data indicate
that its mechanism of action depends on the peptide concentration in the 0.1–1 µM range: while the
impact of 0.1 µM CNP is fully relayed by the AmiC sensor, the CNP anti-biofilm effect observed at
1 µM seems to be only partly relayed by AmiC. Taken together, these data suggest that CNP uses
another not-yet elucidated pathway to achieve its full effect on the bacteria (Figure 7).
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Figure 7. Schematic model representing the mechanism of action of the CNP on P. aeruginosa depending
on the concentration in the vicinity of the bacteria. CNP could bind AmiC sensor after directly entering
into the bacteria (CNP 1 µM) or through PA4858 [41] (1) (CNP 1 µM and 0.1 µM). The direct entrance of
CNP (1 µM) could trigger bacterial stress response explaining the enhancement of virulence previously
described [40] (2), and the reduction of both adhesion and biofilm formation. In parallel, the binding
of CNP to AmiC will release AmiR protein that allows transcription of the whole ami operon leading
to an overproduction of the AmiE enzyme that was shown to reduce both biofilm formation (3) and
virulence (3) [52].
The next step of our study was dedicated to the identification of the putative additional effect
of CNP when the peptide is used at 1 µM. It was shown that another member of the natriuretic
peptide family, the Brain Natriuretic Peptide (BNP) exhibited an antimicrobial activity against a large
spectrum of micro-organisms [39]. This effect was observed only at high peptide concentration (36 µM).
Since we have previously observed that 1 µM BNP mimicked fully the CNP effect on P. aeruginosa
cytotoxicity traits [51], and partly on production of virulence factors [40], and inhibited biofilm
formation with the same efficiency as CNP [41], we investigated a possible anti-bacterial effect of the
CNP peptide. We ruled out this hypothesis since CNP has no impact on P. aeruginosa growth at any
tested concentration. It was shown that several natriuretic peptides including CNP and CNP-derived
peptide were able to affect membrane structures by forming pores in reconstituted membrane [53,54],
suggesting that CNP could insert himself in biological membranes, similarly to CAMP peptides
such as magainin-2 or defensins [55]. In this context, we investigated the possible influence of CNP
on membrane fluidity. Using a fluorescent probe, we observed that CNP used at 1 µM enhances
significantly P. aeruginosa membrane fluidity whereas at the concentration of 0.1 µM the peptide has
no influence on membrane fluidity. These data strongly suggest that the part of the effect provoked by
CNP at 1 µM on P. aeruginosa biofilm formation that was not supported by AmiC binding could be due
to a non-specific effect involving a membrane fluidity alteration.
Another possible explanation is that CNP could modify the matrix production during biofilm
formation or could affect the bacterial ability to attach onto glass slides. In agreement with this
hypothesis, we observed that P. aeruginosa exposed to CNP at 1 µM produced two-fold less
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di-rhamnolipid Rha-Rha C10-C12. This effect appeared highly specific to CNP since BNP, used at
the same concentration, had no impact on rhamnolipid production (data not shown). In addition,
using qRT-PCR approach we have observed that the expression level of envC, which was described to
be involved in intrinsic resistance to CAMPs [56], is reduced by 40% after treatment with CNP (1 µM;
3 h) (data not shown). The resistance mediated by EnvC has been previously linked to increased surface
negativity and hydrophobicity [56]. The higher hydrophobicity generated by the lower expression
of EnvC in response to CNP may thus explain a less efficient adhesion of CNP-treated cells onto
hydrophilic borosilicate glass used in dynamic condition [57].
To study adhesion, the first step of biofilm construction, the choice of the technique used
(i.e., dynamic or static) is important [58]. In this case, the continuous flow approach allows to explore
the importance of adhesion in the really early step of biofilm construction [58], knowing that the first
20 min are determinant for the success of this process [59]. We observed in the present study that
CNP used at 1 µM significantly reduced the glass surface covered by P. aeruginosa after 2 h. This was
supported by the fact that the pilY1 mRNA level is two-fold decreased 3 h after the addition of CNP
(1 µM) (data not shown). The PilY1 protein of P. aeruginosa has been shown to be essential for type
IV pilus assembly and evidently contributes to cell adhesion and virulence [60,61]. Even if these
expression data were obtained from planktonic culture, CNP could be able to repress pilus formation,
which can explain the observed decrease in attachment to glass.
Another hypothesis is the possible trigger of bacterial stress induced by CNP at 1 µM that finally
could explain the default in biofilm formation through bacterial membrane fluidity enhancement [48].
Indeed, it has been proposed that P. aeruginosa cells within biofilms reduced their membrane fluidity
through an enhancement of the number of saturated fatty acids into the membrane [48]. Herein,
we observed that CNP both enhances membrane fluidity and reduces biofilm formation. We can
speculate that the impact of CNP on membrane fluidity could reduce the stability of the biofilm
during its formation process. It has been shown that the extra cytoplasmic function sigma factor
SigX is involved in membrane fluidity modification through fatty acids synthesis regulation [62].
This phenomenon allows P. aeruginosa to quickly adapt its physiology during stresses. In this context,
we observed by qRT_PCR assays that when P. aeruginosa is exposed to 1 µM of CNP the level of sigX
mRNA is increased by 70%, 3 h after the addition of CNP (data not shown).
Besides these data obtained in planktonic condition, we cannot neglect the role played in the
biofilm formation by the ami operon products and especially the enzyme amidase AmiE, since this
operon is over-expressed when the bacteria are exposed to CNP [41]. Indeed, the amiE mRNA
production was demonstrated to be increased 18 and 34 fold when bacteria were grown in biofilm
compared to planktonic and dispersed states, respectively [63]. In addition, the AmiE protein
concentration was shown to be regulated during biofilm formation since its amount was strongly
enhanced when compared with bacteria grown in planktonic state [64,65]. The crucial role of AmiE
in the CNP-related effect on biofilm formation was finally confirmed by a study showing that a
P. aeruginosa strain over-producing the AmiE enzyme was strongly impaired in its ability to form a
biofilm [52] in conditions identical to the one used in the present study.
In conclusion, our data show that the contact between the CNP at 1 µM and P. aeruginosa
triggers a bacterial response that finally decreases the biofilm formation ability and activates a stress
answer favoring bacterial virulence (Figure 7). This dual effect is abolished when the peptide is
less concentrated (0.1 µM), which induces only a strong reduction of biofilm formation after CNP
binding to AmiC. Taken together, these data highlight an interesting future use of CNP as a potential
anti-P. aeruginosa biofilm agent, and strongly suggest that 0.1 µM concentration would be a suitable
window for a therapeutic approach. However, it must be kept in mind that hormones in general,
and CNP especially, are present at low concentration in healthy human blood. Since natriuretic
peptides are already used as drugs in humans [66,67] and since CNP exerts both anti-inflammatory
and anti-fibrotic activities in mouse lungs [68], side effects of CNP used at 0.1 µM cannot be excluded
and should be evaluated in pre-clinical trials. Nevertheless, whatever the outcome of this essential
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evaluation in pre-clinical trials, our study has allowed for identification of bacterial AmiC as the sensor
activated by CNP. Identifying this kind of bacterial target is a good start to design new drugs able to
bind and activate the “hormonal” bacterial sensor without affinity for the natural receptor expressed
in human cells. Taken together, our work reinforces the idea that studying the impact of hormones on
bacteria virulence will allow to identify new targets in bacteria to counteract their pathogenicity.
4. Materials and Methods
4.1. Bacterial Cultures and Tested Molecules
Pseudomonas aeruginosa PA14 wild-type and PA14 ∆amiC strains were obtained from Harvard Medical
School (Boston, MA, USA) [69] and kindly provided by the Biomerit Research Centre (Univ. Cork,
Cork, Ireland). P. aeruginosa PAO1 strain was obtained from an international collection [40]. Bacterial
cultures realized in Luria Bertani (LB) medium were exposed to the tested molecule—the
human CNP (CNP1-22 (Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-
Ser-Gly-Leu-Gly-Cys [disulfide bridge: 6–22]); Polypeptide, Strasbourg, France), resuspended in sterile
water or to sterile water alone (control). The density of the bacterial suspension was determined by
absorption at 580 nm using a spectrophotometer (ThermoSpectronics, Cambridge, UK). The bacterial
density and the absence of contamination were controlled by plating.
4.2. Kinetics of Bacterial Growth
For the monitoring of bacterial growth, an overnight bacterial culture in LB medium was diluted
at OD580 = 0.08 in fresh LB medium. Bacterial culture was dispatched (2 mL for each condition)
with CNP diluted at different concentrations (1 µM to 1 nM) or without CNP (control condition).
Immediately after, 200 µL of each bacterial suspension were dropped in a sterile 100-well flat-bottomed
plastic culture plate (Honeycomb, Bioscreen, Helsinki, Finland). The plate was incubated for 24 h at
37 ◦C under constant agitation in a Bioscreen C. The OD of each well was measured at 580 nm every
15 min.
4.3. Biofilms Formation on Glass Slides Under Dynamic Conditions and Adhesion Analysis
Biofilms formation and adhesion were performed under hydrodynamic conditions in a
three-channel flow cell (1 mm × 4 mm × 40 mm Biocentrum, DTU, Denmark) [70]. The flow
system was assembled, prepared and sterilized as described by Tolker-Nielsen and Sternberg [71].
The substratum consisted of a microscope glass coverslip (24 × 50 KnittelGlasser, Braunschweig,
Germany). Bacteria were grown at 37 ◦C in 10 mL LB broth under shaking. After 2 h, CNP was added
(1 µM to 1 nM) and bacterial growth was pursued for 3 h. Bacterial cells were then harvested by
centrifugation (10 min, 7500 rpm) and washed twice with sterile physiological solution (NaCl 0.9%).
Each channel of the flow cell was inoculated with 300 µL of bacterial suspension diluted to an
OD580nm of 0.1. A 2 h attachment step was performed without any flow. LB medium with or without
CNP (1 µM to 1 nM) was then pumped with a 2.5 mL·h−1 flow during 24 h.
Adhered cells or biofilms formed by P. aeruginosa were stained with fluorescent dyes and observed
by confocal laser scanning microscopy (CLSM). Cells were stained by injecting into each flow cell
channel 300 µL of 5 µM Syto61 or Syto9 (Molecular Probes, Invitrogen, Carlsbad, CA, USA) prepared
in sterile physiological solution (0.9% NaCl, SPS), incubated at room temperature for 15 min in the
dark and then washed for 15 min by a flow of medium (2.5 mL·h−1). CLSM observations were
then immediately performed with a Zeiss LSM710 (Carl Zeiss Microscopy, Oberkochen, Germany)
using a 40× oil immersion objective. Syto 9 and Syto 61 were excited at 488 and 633 nm respectively.
Fluorescence emission was detected from 500 to 550 nm for Syto 9 and from 640 to 660 nm for
Syto 61. Images were taken every micrometer throughout the whole biofilm depth. For visualization
and processing of three-dimensional (3D) image, the Zen 2.1 SP1 software (Carl Zeiss Microscopy,
Oberkochen, Germany) was used. Quantitative analyses of images stacks were performed using the
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COMSTAT software (http://www.imageanalysis.dk/) [72]. For attachment assays, the percentage
of surface covered by bacteria was evaluated using ImageJ software (National Institutes of Health,
Bethesda, MD, USA).
4.4. Fluorescence Anisotropy Microplate Assays
Fluorescence anisotropy analysis of PA14 was performed as described by Vincent et al. [49] with a
few modifications. Bacteria were grown at 37 ◦C in 10 mL LB broth under agitation; after 2 h growth
CNP was added (1 µM or 0.1 µM) and bacterial growth was pursued for 3 h. Bacterial cells were then
harvested by centrifugation, washed twice in 10 mM MgSO4 (5 min, 7500 rpm) and resuspended in
the same wash solution to an OD580 of 0.1. 1 µL of a 4 mM stock solution 1,6-diphenyl-1,3,5-hexatriene
(DPH) (Sigma-Aldrich, Saint-Quentin Fallavier, France) in tetrahydrofuran was added to a 1 mL
aliquot of the resuspended cultures and incubated in the dark for 30 min at 37 ◦C to allow the probe to
incorporate into the membrane bilayer. Measurement of the fluorescence polarization was performed
using the Spark 20M multimode Microplate Reader, a polarization spectrofluorimeter from Tecan
Group Ltd., Männedorf, Switzerland equipped with Te-CoolTM, an active temperature regulation
system. Excitation and emission wavelengths were set to 365 and 425 nm, respectively, and the
anisotropy (r) was calculated according to Lakowicz [73]. Three measurements were performed for
each sample and data were recorded using SparkControlTM software (Version 2.1, Tecan Group Ltd.,
Männedorf, Switzerland). Fluorescence polarization and membrane fluidity are inversely related
since increasing anisotropy values correspond to a less fluid membrane environment and vice versa.
All values are reported as means of triplicate analyses for each experimental variable.
4.5. Rhamnolipid Quantification
Rhamnolipids were extracted and characterized as described previously [74,75]. P. aeruginosa
PAO1 was grown in nutrient Broth n◦2 medium (BNO) (AES, Bruz, France) with either physiologic
water (control) or CNP at 37 ◦C, in shaking conditions at 180 rpm. After 6 h of incubation, bacterial cells
were collected and centrifuged at 7000 g for 10 min. The supernatant was filtered (0.22 µm) and
analyzed by reverse-phase liquid chromatography coupled with negative-ion electrospray ionization
and ion trap mass spectrometry (LC-MS-MS). For each analysis, 20 µL were injected onto a C18 HPLC
column (200× 2 mm, particle size 5 µm). A water-acetonitrile gradient containing 4 mM of ammonium
acetate was used. During 4 min, the percentage of acetonitrile in water was kept at 35%, increased to
50% during 5 min, remained at 50% for 6 min and raised to 90% during last 15 min. The HPLC flow
rate was 200 µL/min but only 20% was introduced into the mass spectrometer. The electrospray
source parameters were: pressure nebulizer, 15 psi; dry gas flow, 7 L/min, dry temperature, 300 ◦C.
Mass scan was extended from 50 to 800 m/z. The proportion of each rhamnolipid was quantified from
the corresponding m/z [M − H]-chromatograms by the measure of peak areas.
5. Statistical Analysis
The non-parametric Mann-Whitney test was used to compare the means within the same set of
experiments using the Past3x software.
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